4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow bococizumab: new trials by email Literature Review of bococizumab trials Research Report on bococizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects Bococizumab (PF-04950615;RN316), Placebo, Ezetimibe - Hypercholesterolemia | Phase 2 | Completed | Pfizer | 218 | 2014-03-01 | 2019-02-08 |
| Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin PBO, 200mg PF-04950615 (RN316), 300mg PF-04950615 (RN316) - Hypercholesterolemia | Phase 2 | Completed | Pfizer | 354 | 2012-07-01 | 2017-12-05 |
| A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins Placebo, Statin, PF-04950615 (RN316) - Hypercholesterolemia, Dyslipidemia | Phase 2 | Completed | Pfizer | 93 | 2011-07-01 | 2017-10-11 |
| A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins Placebo, PF-04950615 (RN316) - Hypercholesterolemia, Dyslipidemia | Phase 2 | Completed | Pfizer | 46 | 2011-06-01 | 2017-11-08 |
Hypercholesterolemia (4) · Dyslipidemias (2)
Pfizer (4)
United States (3) · Canada (2) · Japan (1)
PMID 37994400, PMID 28181260, PMID 29037448, PMID 25784512, PMID 28539539, PMID 31549625